Anixa Biosciences Inc — Director's Dealing 2021

Feb 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2021-02-03

Reporting Person: Titterton Lewis H jr (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-03	Common Stock	G	200000	—	Disposed	820326	Direct

Footnotes

F1: Comprised of two separate bona fide gift transactions exempt under Rule 16b-5.